ABSTRACT
Patients with ulcerated melanoma have shorter diseasefree and overall survival than do patients with nonulcerated melanoma, and the presence of ulceration is included as an independent prognostic factor defining the T stage in the American Joint Committee on Cancer's (AJCC's) melanoma staging criteria. 1,2 Interestingly, ulceration is not only a prognostic marker but also a predictive marker for improved survival after treatment with adjuvant interferon. 3, 4 Accurate assessment of ulceration is therefore crucial for proper staging and clinical management but can be difficult even for experienced pathologists. There is currently no evidencebased definition of ulceration and no consensus in the published literature. The AJCC has defined ulceration as the absence of an intact epidermis overlying a major portion of the primary melanoma based on microscopic examination of the histologic sections. 5 Other studies have defined ulceration as full-thickness loss of epidermis associated with a host reaction (infiltration with neutrophils and/or Upon completion of this activity you will be able to:
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© American Society for Clinical Pathology fibrin deposition). 6 Interestingly, a former study showed that the interobserver reproducibility increased by defining ulceration as a full-thickness epidermal defect (including absence of stratum corneum and basement membrane), with evidence of host response (ie, fibrin deposition, neutrophils) and thinning, effacement, or reactive hyperplasia of the surrounding epidermis. 7 Although ulcerated lesions have been associated with the above-mentioned involvement of the surrounding epidermis, the prognostic impact of these changes remains poorly investigated. So-called consumption or thinning of epidermis (COE) and cleft formation (CF) in the dermal-epidermal junction are epidermal changes associated with ulceration. 8, 9 These phenomena are interesting since they may indicate early structural changes and be possible precursors of ulceration, while reactive epidermal hyperplasia (increased thickness of epidermis) and reepithelialization (a thin few-layered epidermis under or at the edges of a scab) are more likely seen subsequent to the ulceration and inflammation.
Previous studies found that the extent of ulceration seemed to stratify prognosis more accurately than the mere presence or absence of ulceration. 6, [10] [11] [12] In a recent study of localized melanoma, In 't Hout et al 6 classified ulceration both in terms of its maximum diameter (in millimeters) and as a percentage of the tumor's maximum diameter. Stratification of ulcerated melanoma into excessive (≥5 mm or ≥70%) or minimal/ moderate ulcerations (<5 mm or <70%) provided additional prognostic information and showed that excessive ulceration had a significantly negative effect on melanoma-specific survival. 6 In addition, two different types of nontraumatic ulceration or patterns of epidermal infiltration have been described. In infiltrative ulceration, the tumor cells largely infiltrate or erode the epidermis; in attenuative ulceration, nodular growth rather seems to stretch the epidermis with thinning and eventually disruption to follow. 13, 14 To our knowledge, the possible impact of the different types of ulceration on survival has never been evaluated.
We therefore aimed, first, to characterize the presence, type, and extent of ulceration and epidermal involvement, and, second, to evaluate the possible impact of these factors on melanoma-specific survival, allowing better stratification of ulcerated lesions.
Materials and Methods

Patients
In this retrospective follow-up study, we included Danish patients diagnosed with primary cutaneous melanoma from January 1, 2001, through December 31, 2008. Inclusion criteria were superficial spreading and nodular-and lentigo-malignant melanoma. Acral and mucosal melanomas were excluded because of their low prevalence and because of the hypothesized different nature of their tumor biology. Melanomas with described ulceration were located (n = 207) from pathology files and matched consecutively with a reference group of nonulcerated melanomas (n = 207). The melanomas were matched according to Breslow thickness (<1 mm, 1-2 mm, 2-4 mm, 4-6 mm, and ≥6 mm) and age (year of birth: 1900-1920, 1910-1920, etc) . Patients with more than one melanoma were excluded to avoid follow-up bias. Data on pathologic parameters and follow-up information pertaining to the included patients were collected from electronic patient files, pathology files, and the Danish Melanoma Group database. Tumors with no sufficient tumor tissue left, missing follow-up information, or which, after reevaluation, instead of a primary melanoma represented metastatic, satellite, or benign lesions were excluded (n = 17).
All primary tumor sections used for the initial diagnosis were evaluated by a senior pathologist (T.S.) to verify ulcerated status. The section with the thickest tumor tissue and the largest ulcerated area was chosen for the analyses. Tumors were excluded (n = 12) if proper estimation and distinguishing between tumor and trauma-induced ulceration was impossible due to large artifacts, fragmented sections, or insufficient tumor tissue. When the chosen section was sliced, 8% (n = 17) of the tumors initially defined as ulcerated were converted to nonulcerated, while 4% (n = 9) of the tumors originally defined as nonulcerated were converted 
Histopathology
The paraffin-embedded, H&E-stained sections were evaluated to determine the status (presence vs absence), extent (percentage of the total tumor length), and the type (infiltrative vs attenuative) of ulceration in 385 patients with cutaneous melanoma. Furthermore, the presence and type of epidermal involvement, including COE, CF, reepithelialization, and reactive epidermal hyperplasia, were assessed (definitions to follow). The slides were scanned with a slide scanner (Hamamatsu Photonics, Hamamatsu, Japan) and evaluated (M.L.B.-B.), as well as blinded for clinical outcome, by using computer software from an NDP viewer (Hamamatsu). A senior pathologist (T.S.) performed interobserver evaluation (n = 100) of all mentioned factors.
Ulceration: defined as full-thickness loss of epidermis overlying melanoma tissue in which epidermal loss was associated with a host reaction (infiltration of neutrophils and/ or fibrin deposition).
Ulceration extent: measured as the ratio (percentage) of the maximal diameter of ulceration (in millimeters) to the maximal diameter of the dermal-invasive tumor component (in millimeters) using computer measurements (software from the NDP viewer) ❚Image 1❚. If more than one area of ulceration was present, the largest ulceration was measured. For statistical evaluation, a cutoff value of 70% or less was used, according to previous results. 6 Ulceration type: categorized as infiltrative or attenuative. In infiltrative ulceration ❚Image 2❚, melanoma cells infiltrate and erode the epidermal layer; in attenuative ulceration ❚Image 3❚, nodular growth stretches and eventually disrupts the epidermal layer, with minimal epidermal infiltration. 13, 14 COE (general thinning of epidermis): defined as general epidermal thinning (involving more than two-thirds of the epidermis) and loss of rete ridge configuration in areas with direct contact to underlying melanoma tissue ❚Image 4A❚. Focal thinning of the epidermis under or at the edges of a scab was therefore not defined as COE.
COE type: categorized as previously described for ulceration type; infiltrative thinning (Image 2), where epidermis is eroded thin, or attenuative thinning (Image 3), where epidermis is stretched thin.
CF: defined as intact epidermis with CF in the dermalepidermal junction overlying tumor tissue, exceeding 0.3 mm in length, categorized as linear, single-nest, or multinest configuration. 9 Illustrated with immunohistochemistry and staining for CD34-positive endothelial cells, CF was also classified due to its possible nature as either infiltrative CF (associated with focal thinning of the overlying epidermis) or vascular CF (sealed with CD34-positive endothelial cells) ❚Image 5❚.
Reepithelialization: a thin, few-layered epidermis under or at the edges of a scab ❚Image 4B❚.
Reactive epidermal hyperplasia: enlargement of epidermis, with increased epidermal layers and elongated rete ridges ❚Image 4C❚. Previously described as simple diffuse epidermal thickening. 15 
Statistical Analysis
The comparison of patient characteristics between cases and controls was performed using conditional logistic © American Society for Clinical Pathology regression analysis. The study end point was melanomaspecific survival (time from date of surgery to date of death with verified relapse or systemic metastasis). Data on survival and relapse were updated in March 2013. Statistical analysis of the melanoma-specific survival was performed using Cox proportional hazards with a robust sandwich covariance matrix estimate to account for the case-control design. 16 Breslow thickness, sentinel node status, and ulceration, main factors defining the stage, all demonstrated independent prognostic impact in our study cohort and were adjusted for in the multivariate analysis. Age was not adjusted for, since we chose melanoma-specific survival as the end point. Model assessment has been performed evaluating cumulated martingale residuals. Survival probabilities were estimated using the Kaplan-Meier method.
Results
Reproducibility
A total of 100 randomly selected sections were used to test the interobserver reproducibility (T.S. and M.L.B.-B.) to ensure a sufficient number for analysis of all relevant factors. Excellent interobserver agreement was obtained for the measurement of ulceration extent (agreement, 95%; k, 0.86), and good interobserver agreement (agreement, 82%; k, 0.72) was obtained by categorizing patients based on ulceration extent and epidermal involvement (1, no ulceration; 2, moderate ulceration without epidermal involvement; 3, moderate ulceration with epidermal involvement; and 4, excessive ulceration). By categorizing patients based on ulceration status and type (1, ulceration absence; 2, infiltrative ulceration; and 3, attenuative ulceration), good reproducibility was obtained (agreement, 81%; k, 0.70). All disagreements were reevaluated, and we found no systematic disagreement and chose consequently to use the results obtained from M.L.B.-B. for the statistical analysis.
Known Prognostic Markers and Survival
Baseline patient characteristics along with known prognostic parameters are presented in ❚Table 2❚. The study cohorts were matched according to Breslow thickness and age, and no significant difference was observed between the groups with regard to these two factors. There were no differences in Clark level, histologic type, sex, location of the primary melanoma, or sentinel node status between the ulcerated and the nonulcerated groups. The median follow-up period was 7.3 years (37 days to 12.1 years) for melanomaspecific survival.
Increased Breslow thickness, age older than 50 years, presence of ulceration, and positive sentinel node status were significantly independent predictors of short melanomaspecific survival ❚Table 3❚, while no significant independence was observed for Clark level, histologic type, sex, and location (data not shown).
Ulceration Extent
Ulceration was present in 46% of the included tumors (n = 179). Excessive ulcerations (≥70%), measured as ulceration length/total tumor length, were found in 25% (n = 44) of the tumors, while minimal to moderate ulcerations (<70%) The median length of ulceration (in millimeters) for the group of melanomas with ulceration more than 70% was 6.6 mm (95% CI, 6.2-7.8). Excessive ulceration (≥70%) was a significant prognostic factor for melanoma-specific survival in multivariate analysis (hazard ratio [HR], 3.57; 95% CI, 2.01-6.36; P < .0001) with no ulceration as reference ❚Figure 1A❚ (Table 3 ). The extent estimated as a percentage separated the ulcerated groups significantly (P = .001).
Measuring ulceration length as an exact value (in millimeters), a significantly poorer survival was seen for patients with ulcerated lesions more than 3 mm, while cutoff values of 3 mm, 11 5 mm, 6 or 6 mm 10 separated the ulcerated groups in multivariate analysis (data not shown).
Type of Ulceration and Epidermal Infiltration
The infiltrative type of ulceration was found in 52% (n = 93) and the attenuative type in 34% (n = 60), while unclassified ulceration was seen in 14% (n = 26) of the cases (Table 4) . The inability to classify ulceration status was due mainly to total absence of epidermis or a reactive, hyperplastic epidermis.
Attenuative ulceration was an independent prognostic factor for melanoma-specific survival in multivariate analysis (HR, 3.02; 95% CI, 1.82-5.01; P < .0001) with no ulceration as the reference (Table 3) . Also, the type of ulceration separated the ulcerated groups significantly (P = .008). There was a significant association between ulceration type and histologic type. Sixty-seven percent of the superficially spreading melanomas displayed an infiltrative type of ulceration, while 55% of the nodular melanomas displayed an attenuative type of ulceration (P = .007). Adjusting also for the histologic type in the multivariate analysis, an attenuative type of ulceration was still an independent prognostic factor (HR, 3.15; 95% CI, 1.90-5.21; P < .0001) when no ulceration was set as the reference.
Presence of COE was observed in 36% of the included tumors (regardless of ulceration status) (n = 139), of which 49% (n = 73) displayed an infiltrative type, 44% (n = 66) were an attenuative type, and 7% (n = 11) were impossible to classify (Table 4) . Interestingly, an attenuative type of consumption was, like an attenuative type of ulceration, a marker of poor melanoma-specific survival in multivariate analysis (HR, 2.06; 95% CI, 1.20-3.52; P = .009) ❚Figure 1B❚ (Table 3) .
Ulceration, a Heterogeneous Phenomenon
There was a significant correlation between excessive and attenuative ulceration (P < .0001), with only seven melanomas displaying excessive infiltrative ulceration. Combining ulceration extent and type, the tumors were classified into groups of minimal to moderate infiltrative ulceration (n = 86), minimal to moderate attenuative ulceration (n = 35), excessive infiltration (n = 7), excessive attenuative ulceration (n = 25), and unclassified ulcerations (n = 26). Survival analysis showed a significant difference in 5-year survival rates among minimal to moderate infiltrative ulceration (75.8%; 95% CI, 65.1%-83.7%) and excessive attenuative ulceration (28.4%; 95% CI, 47.4%-12.0%) ❚Figure 1C❚.
COE and CF as Possible Precursors of Ulceration
Consumption was significantly associated with increased Breslow thickness, with 18% (n = 8) of the thin melanomas (<1 mm) displaying COE compared with 46% (n = 84) of the thicker melanomas (2-4 mm) (P < .0001). There was also a significant association between COE and ulceration, with 25% of nonulcerated melanomas and 52% of the ulcerated tumors displaying COE (P < .0001). Concerning other patient characteristics, we found that COE was present in 31% of superficially spreading melanomas, 46% of nodular melanomas, and 64% of lentigo maligna melanomas (P = .005), and the presence of COE increased significantly with increased age (P = .005). There was no correlation between COE and sex, location, or sentinel node status.
CF was present in 37% of the tumors (n = 143), of which 36% presented a linear configuration, 11% a single-nest configuration, and 42% a multinest configuration. Illustrated by immunohistochemistry and stains for CD34-positive endothelial cells, we can demonstrate that 19% (n = 27) of the tumors with CFs were associated with vessels in the dermal-epidermal junction, while 72% (n = 103) of CFs were associated with infiltrative epidermal growth and focal thinning of the overlying epidermis, and 9% (n = 13) were unable to be classified because all were equally distributed between the described configurations (linear, single nest, and multinest). CF was significantly correlated with an increased Breslow thickness (P < .0001) and the presence of ulceration (P < .0001), while no significant association was seen between CF and positive sentinel node status, histologic type, age, sex, or location. The presence and type of CF had no prognostic value (data not shown).
Reactive Epidermal Hyperplasia and Reepithelialization Subsequent to Ulceration
The presence of reactive epidermal hyperplasia (enlargement of the epidermis) and/or reepithelialization (a thin, few-layered epidermis under or at the edges of a scab) was observed in 50 (13%) of the included tumors, with significant correlation to ulcerated lesions (P > .0001). In multivariate analysis with no ulceration and normal epidermis as the reference, only minimal to moderate ulceration with epidermal involvement (HR, 1.78; 95% CI, 1.02-3.09; P = .041) and excessive ulcerations (HR, 4.14; 95% CI, 2.19-7.84; P < .0001) had independent prognostic value ( Table 3 ). The 5-year survival rate for patients with no ulceration and normal epidermis was 85.8% (95% CI, 79.1%-90%), equivalent to patients with minimal to moderate ulceration without epidermal involvement of the surrounding epidermis (83.6%; 95% CI, 68.6%-91.8%) ❚Figure 1D❚. No difference in the median extent of ulceration was seen between the groups having minimal to moderate ulceration with epidermal involvement (26.5%; 95% CI, 21.4%-33.4%) and minimal to moderate ulceration without epidermal involvement (29.4%; 95% CI, 22.5%-38.9%).
Discussion
We performed a detailed analysis of ulcerated melanomas in 179 patients compared with 207 patients with nonulcerated melanomas and found that excessive ulceration, measured as a percentage of the total tumor length (≥70%), was an independent predictor of poor survival compared with minimal to moderate ulceration (<70%). It has been known for decades that the presence of ulceration is an important prognostic factor in primary melanoma. 15 Already in the early 1980s, it was suggested that the width of ulceration was important for staging. [10] [11] [12] In line with these observations, In 't Hout et al 6 recently reported that the extent (width) of ulceration measured in millimeters (≥5 mm) or as a percentage of the total tumor length (≥70%) was a stronger prognostic marker than the mere presence of ulceration. This study included 521 ulcerated and 4140 nonulcerated patients with localized melanoma. The presence of ulceration was an independent predictor of poor melanoma-specific survival (HR, 1.55; P < .001). Patients with minimal ulcerations (<70%) had a significantly higher risk of death (HR, 1.53) compared with those with nonulcerated melanoma, as did patients with excessive ulcerated tumors (≥70%) (HR, 2.20). 6 In 't Hout et al also reported a significantly poorer melanoma-specific survival in patients with melanomas with an ulceration diameter of 5 mm or more and proposed that a diameter of 5 mm should be used as a cutoff value. Earlier studies have suggested cutoff values of 3 mm 11,12 or 6 mm. 10 In univariate analysis, we found significantly poorer survival of patients with ulceration measuring more than 3 mm, while cutoff values of 3 mm, 5 mm, or 6 mm separated the ulcerated groups in multivariate analysis. We therefore suggest that 
Including the Extent of Ulceration and Involvement of the Surrounding Epidermis
Epidermal involvement was defined as the presence of COE, reepithelialization, and/or reactive epidermal hyperplasia. Categorizing patients based on the extent of ulceration and epidermal involvement, 25% (n = 44) showed minimal to moderate ulceration without epidermal involvement, 50% ulceration extent, measured in terms of percentage of the total tumor length, provides a more accurate measure because it includes tumor size and stratifies prognosis more accurately than the mere presence vs absence of ulceration.
Convincing explanations as to why the degree of ulceration holds prognostic value have not been presented. If ulceration is an ongoing progressive phenomenon, it is possible that excessive ulcerations have been present for a longer time. A more likely explanation is that these tumors host an increased inflammatory response that contributes to a protumoral microenvironment and supports the tumor cells to have increased proliferation and dissemination.
In addition to the extent, we report that the type of ulceration or the pattern of epidermal infiltration has prognostic impact. We found that an attenuative type of ulceration was an independent predictor of poor melanomaspecific survival compared with both an infiltrative type and nonulcerated lesions. Scolyer et al 13 previously described the different types of ulceration, while the prognostic significance of this factor to our knowledge never has been evaluated. In our cohort, the histologic type (superficial spreading vs nodular) had no independent prognostic value, but it correlated significantly with the type of ulceration. Thus, 67% of the superficially spreading melanomas were of the infiltrative type, while 55% of the nodular melanomas were of the attenuative type (P = .007). To verify that the prognostic impact of the type of ulceration was not rooted in the results of the histologic type, we also adjusted for this factor in a multivariate analysis. After adjustment, an attenuative type of ulceration retained its independent significance. Interestingly, we combined the described pattern of ulceration with the presence of consumption and demonstrated that the type of epidermal infiltration had prognostic impact regardless of ulcerated status. We found that an attenuative type of consumption was an independent marker of melanomaspecific survival as opposed to both an infiltrative type and lesions without consumption, in line with the prognostic impact of the attenuative type of ulceration. The interobserver reproducibility of the type of ulceration was fair to good, a Ulceration: full-thickness loss of epidermal matrix associated with a host reaction (neutrophils and/or fibrin deposition). b Ulceration type: infiltrative; tumor cells infiltrate and erode the epidermis vs attenuative; nodular growth stretches and disrupts the epidermis. c Ulceration extent: estimated as ulceration length over total tumor length (percentage). d Consumption of epidermis: thinning of the epidermis (involving more than two-thirds of the total epidermis length) with loss of normal rete ridge configuration. e Consumption of epidermis type: infiltrative; epidermis is largely infiltrated and eroded thin vs attenuative; nodular growth stretches the epidermis thin. f Reactive epidermal hyperplasia: enlargement of epidermis, with increased epidermal layers and elongated rete ridges. Reepithelialization: a thin and few-layered epidermis under or at the edges of a scab.
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© American Society for Clinical Pathology but due to the subjectivity of the measurement, it might be difficult to implicate in a clinical setting. Distinction between the different patterns of epidermal infiltration is interesting, though, since it may reflect important differences in the biological nature or tumor microenvironments. It has been suggested that infiltrative ulceration is characterized by increased and erosive growth into the epidermal layer, which may disrupt desmosomes and cellular adhesion. In contrast, melanomas with an attenuative type of ulceration show minimal epidermal erosion but expansive growth that may stretch and eventually disrupt the epidermis. 13, 14 We demonstrated that ulcerated lesions are associated with structural changes of the surrounding epidermis, as described in previous studies. CF 9 and COE 17 are interesting phenomena since they may indicate early structural changes and be possible precursors of ulceration, while reactive epidermal hyperplasia (enlargement of epidermis) and reepithelialization (a thin and few-layered epidermis under or at the edges of a scab) are more likely seen subsequent to ulceration and inflammation. CF has been defined as gap formation in the dermalepidermal junction exceeding 0.3 mm in length, with a linear, single-nest, or multinest configuration. 9 We found that CF correlated significantly with an increased Breslow thickness (P > .0001) and the presence of ulceration (P > .0001). However, we were unable to demonstrate that the presence, type, or extent of CF had any prognostic impact. The presence of CF could be due to several factors: artifacts, increased proliferation, and thereby erosion of desmosomes or cell-cell adhesion loss (as described in normal wound healing). We demonstrated that 19% of the tumors displaying CFs are sealed with CD34-positive endothelial cells in the dermal-epidermal junction (Image 5B). We therefore suggest that the presence of CF could also be due to blocked and dilated vessels of the superficial plexus. In 72% of the tumors, CF was associated with infiltrative epidermal growth of melanoma cells and focal thinning of the overlying epidermis, which may be a possible precursor of focal ulceration (Image 5A).
Another interesting phenomenon that theoretically could be a precursor of ulceration is COE. The phenomenon has been defined as thinning of epidermis, attenuation of basal and suprabasal layers, and loss of the normal rete ridge configuration in areas overlying melanoma tissue. 8 In our study, we found that COE was present in 37% of the included melanomas, while this phenomenon in previous studies has been reported between 43% and 86% of all melanomas. 8, 17, 18 Consumption can be detected even in thin melanomas, but the probability of COE rises with increasing tumor thickness. In this study, we showed a significant correlation between the presence of COE and increasing Breslow thickness, where only 18% (n = 8) of the thin melanomas (<1 mm) but 46% (n = 84) of the thicker melanomas (2-4 mm) had COE. We also showed a strong correlation between COE and ulceration, with 25% of nonulcerated melanomas and 52% of the ulcerated tumors showing the presence of COE. These figures are in line with those reported in previous studies. 17, 19 Consumption was first defined and introduced as an important factor for differentiating melanomas from Spitz nevi, 8 whereas Walters et al 17 showed a correlation between COE and ulceration. In this latter study, COE was frequently found at the edges of ulcerated areas, and it was thought of as an early step in the progression toward ulceration. In this study, we defined COE as general thinning, involving more than two-thirds of the epidermis. We did not define thinning of the epidermis only in wound edges or under a scab as COE but rather as a possible instance of reepithelialization. By this classification, COE is more likely a precursor and not a result of ulceration. The presence of a thin epidermis under or at the edges of a scab was seen in this study as a possible instance of reepithelialization, and enlargement of epidermis or elongated rete ridges was considered reactive epidermal hyperplasia. These are described phases during wound healing, subsequent to ulceration and wounding. 20 We observed the presence of these epidermal changes in 13% (n = 50) of the included tumors, with significant correlation to ulcerated lesions. A vital reaction with neutrophils and/or fibrin and the presence of epidermal changes may therefore be important characteristics distinguishing tumor-induced ulceration from traumatic disruption of the epidermis, related to the surgical or preparation procedure. Scratching as a traumatic ulceration may be impossible to distinguish from tumor-induced ulceration, though, since these lesions would present a vital reaction of the underlying melanoma tissue, with an unknown biological and prognostic impact.
Interestingly, by combining the extent of ulceration and the presence of epidermal involvement, we demonstrated equivalent 5-year survival rates for patients with a normal epidermis and patients with minimal to moderate ulceration without epidermal involvement, while patients with minimal to moderate ulceration with epidermal involvement and patients with excessive ulcerations showed significantly poorer survival and were independent prognostic factors in multivariate analysis ( Figure 1D and Table 3 ).
The prognostic significance of ulceration is well established, and its presence upstages patients with localized melanoma by both subcategories and stages. 1 In addition, recent results suggest that ulceration is not only a prognostic marker but also a predictive marker for the response of adjuvant treatment with interferon. 3, 4 A consensual definition and accurate assessment are therefore of great importance for proper staging and clinical management. In this present study, we used a previously described definition 6 and defined ulceration as full-thickness loss of epidermis overlying melanoma tissue, in which epidermal loss was associated with a host reaction (infiltration of neutrophils and/or fibrin deposition). The presence of epidermal involvement of the surrounding epidermis was coded separately. Currently, there is no evidence-based definition of ulceration and no consensus in the published literature. The AJCC has defined ulceration as the absence of an intact epidermis overlying a major portion of the primary melanoma based on microscopic © American Society for Clinical Pathology examination of the histologic sections. 1, 5 Interestingly, by including full-thickness epidermal loss, with evidence of a host response and thinning, effacement, or reactive hyperplasia of the surrounding epidermis, the interobserver reproducibility increased 7 and, as suggested from our results, allowed better prognostic stratification. Further studies including different institutions and trained pathologists would be relevant and represent a limitation to the present study.
In conclusion, despite the limitations of this retrospective study and design, we suggest that ulceration is a heterogeneous phenomenon with independent prognostic impact of both the extent and type of ulceration. Furthermore, the combination of ulceration extent (as a percentage of the ulceration length over the total tumor length) and epidermal involvement (presence of COE, reepithelialization, or reactive epidermal hyperplasia) provided additional prognostic information and may be useful markers, allowing better stratification of ulcerated lesions.
